Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Mehmet Metin Seker"'
Autor:
Nalan A Babacan, Hatice Reyhan Egilmez, Birsen Yücel, Parlak Ilknur, Mehmet Metin Seker, Turgut Kaçan, Aykut Bahçeci, Sener Cihan, Bülent Akinci, Berna Eriten, Saadettin Kiliçkap
Publikováno v:
The Saudi Journal of Gastroenterology, Vol 22, Iss 1, Pp 25-29 (2016)
Background/Aims: This study aimed to examine whether UHRF-1 and p53 overexpression is a prognostic marker for gastric cancer. Patients and Methods: Sixty-four patients with gastric cancer (study group) and 23 patients with gastritis (control group) w
Externí odkaz:
https://doaj.org/article/8e57663b45ca467b843989c38a4daf9e
Autor:
Mehmet Metin Seker, Ali Ugur Uslu, Hatice Ozer, Ayse Seker, Turgut Kacan, Nalan Babacan, Handan Aker, Sahande Elagoz
Publikováno v:
Menopause Review, Vol 13, Iss 6, Pp 356-358 (2014)
Endocervical stromal sarcoma (ECSS) is a very rare uterine sarcoma. The most common presentation is pelvic mass and vaginal bleeding. The mainstay of treatment is surgery. There is no consensus on the adjuvant treatment. Relapses are usually in the p
Externí odkaz:
https://doaj.org/article/9a7b985270c241c6837b3d596d90973f
Autor:
Ahmet Bilici, Sinan Koca, Mustafa Karaagac, Sabin Goktas Aydin, Emrah Eraslan, Muhammed Ali Kaplan, Birol Ocak, Sema Sezgin Goksu, Semra Paydas, Fahri Akgul, Sumeyye Derin, Yakup Ergun, Emre Yekeduz, Cihan Erol, Deniz Tataroglu Ozyukseler, Atike Gokcen Demiray, Mustafa Karaca, Zeynep Gulsum Guc, Serkan Menekse, Havva Yesil Cinkir, Ozge Gumusay, Abdullah Sakin, Ozlem Ozkul, Hacer Demir, Dilek Erdem, Mehmet Besiroglu, Olcun Umit Unal, Ramazan Acar, Lokman Koral, Suleyman Sahin, Teoman Sakalar, Aykut Bahceci, Ahmet Ozveren, Ulug Mutlu Gunaydin, Mehmet Metin Seker, Veli Sunar, Pinar Dal, Mehmet Artac, Serdar Turhal
Aim: Description of patient characteristics, effectiveness and safety in Turkish patients treated with pazopanib for metastatic soft tissue sarcoma (STS). Patients and methods: This multicenter study is based on retrospective review of hospital medic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e475dde06decc907f161d14d4d0f2ae4
https://avesis.deu.edu.tr/publication/details/c895112d-5502-4614-a59b-a819d23aebc3/oai
https://avesis.deu.edu.tr/publication/details/c895112d-5502-4614-a59b-a819d23aebc3/oai
Autor:
Sukru Ozaydin, Caglayan Geredeli, Mehmet Fatih Can, Mahmut Gumus, Özlem Nuray Sever, Abdullah Sakin, Turkan Ozturk Topcu, Abdurrahman Isikdogan, Mehmet Metin Seker, Keziban Nur Pilanci, Muhammet Ali Kaplan, Faysal Dane, Ulku Yalcintas Arslan, Timucin Cil, Nuriye Ozdemir, Mustafa Karaagac, Mehmet Bilici, Zeynep Oruc Seker, Halis Yerlikaya, Mukremin Uysal, Dogan Koca, Asude Aksoy
Publikováno v:
Oncology Research and Treatment. 42:516-522
Background: Colorectal cancer (CRC) is a rare disease amongst children and adolescents. Previous studies have reported a number of differences between children/adolescents, young adults, and adult patients with CRC. However, none of these studies com
Autor:
Yusuf Gunaydin, Alper Sevinc, Mahmut Gumus, Hatice Odabas, Ibrahim Vedat Bayoglu, Esma Turkmen, Nurten Kandemir, Sener Cihan, Z. Urakci, Ahmet Bilici, Turkan Ozturk, Nedim Turan, Fatih Selcukbiricik, Umut Demirci, Mehmet Metin Seker, Bala Basak Oven Ustaalioglu
Publikováno v:
World Journal of Urology. 35:1103-1110
WOS: 000404154000013
PubMed ID: 27812752
Background Currently, it is accepted that risk assessment of clinical stage I (CS I) nonseminomatous germ cell tumors (NSGCT) patient is mainly dependent on the presence of lymphovascular invasion (L
PubMed ID: 27812752
Background Currently, it is accepted that risk assessment of clinical stage I (CS I) nonseminomatous germ cell tumors (NSGCT) patient is mainly dependent on the presence of lymphovascular invasion (L
Autor:
Ersin, Ozaslan, Ulaş Serkan, Topaloglu, Mevlude, Inanc, Umut, Gokmen Erdem, Hacer, Demir, Erkan, Arpaci, Mehmet, Metin Seker, Mustafa, Karaagac, Melih, Kiziltepe, Baki, Eker, Metin, Ozkan
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 22(4)
To evaluate the efficacy and adverse events with cetuximab plus FOLFOX administered as second- and third-line therapy in metastatic colorectal cancer (mCRC) patients.IPatients were administered cetuximab plus FOLFOX as second- and third-line therapy
Autor:
Birsen Yücel, Omer Tamer Dogan, Seyit Ahmet Ertürk, Mehmet Metin Seker, Serdar Berk, Ismail Sari, Zekiye Hasbek, Yavuz Silig
Amaç: Akciğer kanseri dünya genelinde kansere bağlı ölümlerin önde gelen nedenidir. Tanısal cihazlar ve teknolojik gelişmelere bağlı tedavi seçeneklerinde ilerlemeye rağmen, akciğer kanseri hastalarında genel mortalite oranı hala yü
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a22b42f822fa458891b29ac0dd9866a
https://hdl.handle.net/20.500.12418/3592
https://hdl.handle.net/20.500.12418/3592
Autor:
Hatice Odabas, Birsen Yücel, Ilknur Koc Olcas, Ayfer Ay Eren, Saadettin Kilickap, Mehmet Metin Seker, Nalan Akgul Babacan, Turgut Kacan
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 15:151-154
Background: Lung cancer is the most common cause of cancer-related death worldwide. The incidence of lung cancer is aproximately 7-8 thousand percent in Turkish women. In this study, we aimed to evaluate the clinical, pathological properties and surv
Autor:
Birsen Yücel, Mehmet Metin Seker, Turgut Kaçan, Ebru Akkaş Atesever, Mehmet Fuat Eren, Zekiye Hasbek
Publikováno v:
Journal of Medical Updates. 3:109-115
Amaç: Bu çalışmanın amacı baş boyun kanserinde prognostik faktör olarak komorbidite, performans durumu, hemoglobin düzeyi, kilo kaybı, radyoterapiye ara verme ve mukozitin öneminin araştırılmasıdır. Yöntem: Üniversitesimizin Onkoloj
Autor:
Mustafa Gürol Celasun, Nalan Akgul Babacan, Birsen Yücel, Zekiye Hasbek, Turgut Kacan, Mehmet Metin Seker, Mehmet Fuat Eren, Ayfer Ay Eren, Seher Bahar
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 14:6687-6692
WOS: 000329829200086
PubMed ID: 24377589
Background: This study aimed to determine the demographical distribution, survival and prognostic factors for neuroendocrine tumors monitored in our clinic. Materials and Methods: Data for 52 patient
PubMed ID: 24377589
Background: This study aimed to determine the demographical distribution, survival and prognostic factors for neuroendocrine tumors monitored in our clinic. Materials and Methods: Data for 52 patient